tiprankstipranks
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market
SUNPHARMA
Sun Pharmaceutical Industries Limited
RESEARCH TOOLSreports
Holding IN:SUNPHARMA?
Track your performance easily

Sun Pharmaceutical Industries Limited (SUNPHARMA) Stock Price & Analysis

0 Followers

SUNPHARMA Stock Chart & Stats


SUNPHARMA FAQ

What was Sun Pharmaceutical Industries Limited’s price range in the past 12 months?
Sun Pharmaceutical Industries Limited lowest stock price was ₹1360.35 and its highest was ₹1960.20 in the past 12 months.
    What is Sun Pharmaceutical Industries Limited’s market cap?
    Sun Pharmaceutical Industries Limited’s market cap is ₹4.37T.
      When is Sun Pharmaceutical Industries Limited’s upcoming earnings report date?
      Sun Pharmaceutical Industries Limited’s upcoming earnings report date is Jan 31, 2025 which is in 2 days.
        How were Sun Pharmaceutical Industries Limited’s earnings last quarter?
        Sun Pharmaceutical Industries Limited released its earnings results on Oct 28, 2024. The company reported ₹12.7 earnings per share for the quarter, beating the consensus estimate of ₹11.985 by ₹0.715.
          Is Sun Pharmaceutical Industries Limited overvalued?
          According to Wall Street analysts Sun Pharmaceutical Industries Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Sun Pharmaceutical Industries Limited pay dividends?
            Sun Pharmaceutical Industries Limited pays a Annually dividend of ₹13.5 which represents an annual dividend yield of 0.74%. See more information on Sun Pharmaceutical Industries Limited dividends here
              What is Sun Pharmaceutical Industries Limited’s EPS estimate?
              Sun Pharmaceutical Industries Limited’s EPS estimate is 11.98.
                How many shares outstanding does Sun Pharmaceutical Industries Limited have?
                Sun Pharmaceutical Industries Limited has 2,399,276,400 shares outstanding.
                  What happened to Sun Pharmaceutical Industries Limited’s price movement after its last earnings report?
                  Sun Pharmaceutical Industries Limited reported an EPS of ₹12.7 in its last earnings report, beating expectations of ₹11.985. Following the earnings report the stock price went up 2.279%.
                    Which hedge fund is a major shareholder of Sun Pharmaceutical Industries Limited?
                    Currently, no hedge funds are holding shares in IN:SUNPHARMA
                    ---

                    SUNPHARMA Stock 12 Month Forecast

                    Average Price Target

                    ₹2,023.00
                    ▲(18.59% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1393":"₹1,393","1615":"₹1,615","1837":"₹1,837","2059":"₹2,059","2281":"₹2,281"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2280,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹2.28K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2023,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹2.02K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1650,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.65K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1393,1615,1837,2059,2281],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Jan<br/>2025","25":"Jan<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1889.8,1919.8153846153846,1949.8307692307692,1979.8461538461538,2009.8615384615384,2039.876923076923,2069.8923076923074,2099.9076923076923,2129.923076923077,2159.9384615384615,2189.953846153846,2219.9692307692308,2249.9846153846156,{"y":2280,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1889.8,1900.0461538461539,1910.2923076923078,1920.5384615384614,1930.7846153846153,1941.0307692307692,1951.2769230769231,1961.5230769230768,1971.7692307692307,1982.0153846153846,1992.2615384615385,2002.5076923076922,2012.753846153846,{"y":2023,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1889.8,1871.353846153846,1852.9076923076923,1834.4615384615383,1816.0153846153846,1797.5692307692307,1779.123076923077,1760.676923076923,1742.2307692307693,1723.7846153846153,1705.3384615384616,1686.8923076923077,1668.446153846154,{"y":1650,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1394.16,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1553.78,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1625.65,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1497.56,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1455.54,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1513.11,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1715.95,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1816.75,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1919.4,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1849.05,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1808.2,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1808.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1889.8,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Aurobindo Pharma Ltd
                    Cipla Ltd
                    Dr. Reddy's Laboratories Ltd.
                    Lupin Limited
                    Torrent Pharmaceuticals Ltd

                    Best Analysts Covering SUNPHARMA

                    1 Year
                    Shyam SrinivasanGoldman Sachs
                    1 Year Success Rate
                    0/1 ratings generated profit
                    0%
                    1 Year Average Return
                    0.00%
                    reiterated a sell rating 20 days ago
                    Copying Shyam Srinivasan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis